About Ian Ratcliffe
Form D filings for Vitara Biomedical from 2022 to 2024 list Ian Ratcliffe as director.
Ian Ratcliffe first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Ian Ratcliffe in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ian Ratcliffe works with at each company, as listed on that company's latest Form D.
Vitara Biomedical, Inc. · Form D, Oct 28, 2024
TT
Thomas Todorow
Director
MK
Manish Kothari
Director
BL
Bernard Lyons
Interim Chief Executive Officer and director
DN
Diem Nguyen
Director
TF
Ted Fjallman
Director